Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone undecanoate vs metformin vs combination in obese males with hypogonadotropic hypogonadism and erectile dysfunction
2012-000870-51Phase 4Active
- Sponsor
- Unidad de Gestión Clínica de Endocrinología y Nutrición
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypogonadotropic hypogonadism (HH), erectile dysfunction (ED) and obesity comparing Testosterone undecanoate monotherapy, Metformin monotherapy and Combination therapy (testosterone undecanoate + metformin) (3 arms). Primary endpoint: Change in IIEF score at 52 weeks. Started Sep 2012; status: active.
02
Drugs
testosterone undecanoatemetformin
03
Conditions
hypogonadotropic hypogonadism (HH)erectile dysfunction (ED)obesity
Beyond the preview
Go deeper on 2012-000870-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000870-51.